Functional Tumor Volume by Fast Dynamic Contrast‐Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple‐Negative Breast Cancer

Background Dynamic contrast‐enhanced (DCE) MRI is useful for diagnosis and assessment of treatment response in breast cancer. Fast DCE MRI offers a higher sampling rate of contrast enhancement curves in comparison to conventional DCE MRI, potentially characterizing tumor perfusion kinetics more accu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of magnetic resonance imaging 2021-07, Vol.54 (1), p.251-260
Main Authors: Musall, Benjamin C., Abdelhafez, Abeer H., Adrada, Beatriz E., Candelaria, Rosalind P., Mohamed, Rania M.M., Boge, Medine, Le‐Petross, Huong, Arribas, Elsa, Lane, Deanna L., Spak, David A., Leung, Jessica W.T., Hwang, Ken‐Pin, Son, Jong Bum, Elshafeey, Nabil A., Mahmoud, Hagar S., Wei, Peng, Sun, Jia, Zhang, Shu, White, Jason B., Ravenberg, Elizabeth E., Litton, Jennifer K., Damodaran, Senthil, Thompson, Alastair M., Moulder, Stacy L., Yang, Wei T., Pagel, Mark D., Rauch, Gaiane M., Ma, Jingfei
Format: Article
Language:English
Subjects:
Auditory discrimination
Biopsy
Breast cancer
breast MRI
Confidence intervals
DCE MRI
Field strength
functional tumor volume
Injection
Magnetic resonance imaging
Patients
Perfusion
Population studies
Statistical analysis
Statistical tests
Surgery
treatment response
Triple‐negative breast cancer
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Dynamic contrast‐enhanced (DCE) MRI is useful for diagnosis and assessment of treatment response in breast cancer. Fast DCE MRI offers a higher sampling rate of contrast enhancement curves in comparison to conventional DCE MRI, potentially characterizing tumor perfusion kinetics more accurately for measurement of functional tumor volume (FTV) as a predictor of treatment response. Purpose To investigate FTV by fast DCE MRI as a predictor of neoadjuvant systemic therapy (NAST) response in triple‐negative breast cancer (TNBC). Study Type Prospective. Population/Subjects Sixty patients with biopsy‐confirmed TNBC between December 2016 and September 2020. Field Strength/Sequence A 3.0 T/3D fast spoiled gradient echo‐based DCE MRI Assessment Patients underwent MRI at baseline and after four cycles (C4) of NAST, followed by definitive surgery. DCE subtraction images were analyzed in consensus by two breast radiologists with 5 (A.H.A.) and 2 (H.S.M.) years of experience. Tumor volumes (TV) were measured on early and late subtractions. Tumors were segmented on 1 and 2.5‐minute early phases subtractions and FTV was determined using optimized signal enhancement thresholds. Interpolated enhancement curves from segmented voxels were used to determine optimal early phase timing. Statistical Tests Tumor volumes were compared between patients who had a pathologic complete response (pCR) and those who did not using the area under the receiver operating curve (AUC) and Mann–Whitney U test. Results About 26 of 60 patients (43%) had pCR. FTV at 1 minute after injection at C4 provided the best discrimination between pCR and non‐pCR, with AUC (95% confidence interval [CI]) = 0.85 (0.74,0.95) (P 
ISSN:1053-1807
1522-2586
DOI:10.1002/jmri.27557